Conversely, PHF6 served as a favorable prognostic factor for both DSS and OS in glioma (GBMLGG), skin cutaneous melanoma (SKCM), and kidney renal clear cell carcinoma (KIRC) (Figure 2A,B). This evidence concerns the gene PHF6 and central nervous system cancer.